ArticleBlood advances2025

Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy.

Barbara D Friedes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.